Director, Global Product Development
CurrentLead clinical execution of Phase 2 and 3 studies of medium-high complexity and significant business impact. Lead development of Protocols and Amendments. Author and Approve Informed Consent Documents (ICDs) including responses to external stakeholders Review and approve country selection, site selection criteria and ensure protocol specific training. Review safety data, SAE reports, TMEs, DMEs and ensure clinical documents are updated as required. Input and review of the CSR. 2023 Craig Saxton award winner for Excellence in Clinical Development.